Bloodless clinical strategies for management of severe anaemia and hemorrhage

1. Besen BA, Gobatto AL, Melro LM, et al. Fluid and electrolyte overload in critically ill patients: an overview. World J Crit Care Med 2015; 4(2): 116–129.

2. Beverina I, Razionale G, Ranzini M, et al. Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. Blood Transfus 2020; 18(2): 106–116.

3. Bienstock JL, Eke AC, Hueppchen NA. Postpartum hemorrhage. N Engl J Med 2021; 384(17): 1635–1645.

4. Blatný J, Bláha J, Cvachovec K, a kol. Diagnostika a léčba život ohrožujícího krvácení u dospělých pacientů v intenzivní a perioperační péči. Československý mezioborový doporučený postup. Anest Intenziv Med 2017; 28: 263–269.

5. Blatný J. Krvácení a jeho léčba – (nejen) hematologický problém. Interní Med 2009; 11(3): 120–122.

6. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019; 394(10210): 1713–1723.

7. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389(10084): 2105–2116.

8. Feiner JR, Finlay-Morreale HE, Toy P, et al. High oxygen partial pressure decreases anemia-induced heart rate increase equivalent to transfusion. Anesthesiology 2011; 115(3): 492–498.

9. Franchini M, Franchi M, Bergamini V, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 2010; 53(1): 219–227.

10. Georgiou C, Inaba K, DuBose J, et al. Optimizing outcomes in the Jehovah’s witness following trauma: special management concerns for a unique population. Eur J Trauma Emerg Surg 2009; 35(4): 383.

11. Girardis M, Busani S, Damiani E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 2016; 316(15): 1583–1589.

12. Johnson-Arbor K, Verstraete R. Bloodless Management of the anemic patient in the emergency department. Ann Emerg Med 2021; S0196-0644(21)00515-1.

13. Kandane-Rathnayake RK, Isbister JP, Zatta AJ, et al. Australian and New Zealand Haemostasis Registry Steering Committee. Use of recombinant activated factor VII in Jehovah’s Witness patients with critical bleeding. ANZ J Surg 2013; 83(3): 155–160.

14. Klein AA, Bailey CR, Charlton A, et al. Association of Anaesthetists: Anaesthesia and peri-operative care for Jehovah’s Witnesses and patients who refuse blood. Anaesthesia 2019; 74(1): 74–82.

15. Kromker M, Lauscher P, Kertscho H, et al. Anemia tolerance during normo-, hypo- and hypervolemia. Transfusion 2017; 57(3): 613–621.

16. Kudela M, Pilka R, Dzvincuk P, et al. Bloodless surgery and gynecological patients among Jehovahs Witnesses. Čes. Gynekol. 2021; 86(2): 110–113.

17. Lasocki S, Pène F, Ait-Oufella H, et al. Management and prevention of anemia (acute bleeding excluded) in adult critical care patients. Ann Intensive Care 2020; 10(1): 97.

18. Liu Y, Li X, Che X, Zhao G, Xu M. Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial. BMC Pregnancy Childbirth 2020; 20(1): 452.

19. Lošťák J, Gallo J, Večeřa M, a kol. Lokální aplikace kyseliny tranexamové u TEP kyčle snižuje krevní ztráty a spotřebu krevních transfuzí. Acta Chir Orthop Traumatol Cech 2017; 84(4): 254–262.

20. Marinakis S, Van der Linden P, Tortora R, et al. Outcomes from cardiac surgery in Jehovah’s Witness patients: experience over twenty – one years. J Cardiothorac Surg 2016; 11(1): 67.

21. Matsunaga S, Takai Y, Seki H. Fibrinogen for the management of critical obstetric hemorrhage. J Obstet Gynaecol Res 2019; 45(1): 13–21.

22. Muñoz C, Aletti F, Govender K, et al. Resuscitation after hemorrhagic shock in the microcirculation: targeting optimal oxygen delivery in the design of artificial blood substitutes. Front Med (Lausanne) 2020; 7: 585638.

23. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233–247.

24. Muñoz M, Acheson AG, Bisbe E, et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia 2018; 73(11): 1418–1431.

25. Naumann DN, Beaven A, Dretzke, et al. Searching for the optimal fluid to restore microcirculatory flow dynamics after haemorrhagic shock: a systematic review of preclinical studies. Shock 2016; 46(6): 609–622.

26. Neef V, Vo L, Herrmann E, et al. The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery – an observational study in a patient blood management centre. Anaesthesiol Intensive Ther 2021; 53(1): 1–9.

27. Nguyen TN, Boyd ME. Bloodless management of postpartum hemorrhage and Jehovah’s Witnesses. J Obstet Gynaecol Can 2019; 41(6): 743–744.

28. Pařízek A, Binder T, Bláha J, a kol. Diagnostika a léčba peripartálního život ohrožujícího krvácení. Česko-slovenský mezioborový konsenzus. Čes. Gynekol. 2018; 83(2): 151–158.

29. Porter SB, White LJ, Osagiede O, et al. Tranexamic acid administration is not associated with an increase in complications in high-risk patients undergoing primary total knee or total hip arthroplasty: A retrospective case-control study of 38,220 patients. J Arthroplasty 2020; 35(1): 45–51.e3.

30. Resar LM, Frank SM. Bloodless medicine: what to do when you can’t transfuse. Hematology Am Soc Hematol Educ Program 2014; 2014: 553–558.

31. Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013; 17(10): 1–79.

32. Sentilhes L, Sénat MV, Le Lous M, et al. Groupe de recherche en obstétrique et gynécologie. Tranexamic acid for the prevention of blood loss after cesarean delivery. N Engl J Med 2021; 384(17): 1623–1634.

33. Shander A, Brown J, Licker M, et al. Standards and best practice for acute normovolemic hemodilution: evidence-based consensus recommendations. J Cardiothorac Vasc Anesth 2020; 34(7): 1755–1760.

34. Shander A, Goodnough LT. Management of anemia in patients who decline blood transfusion. Am J Hematol 2018; 93(9): 1183– 1191.

35. Shander A, Javidroozi M, Gianatiempo C, et al. Outcomes of protocol-driven care of critically ill severely anemic patients for whom blood transfusion is not an option. Crit Care Med 2016; 44(6): 1109–1115.

36. Shander A, Javidroozi M, Naqvi S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion. Transfusion 2014; 54 (10 Pt 2): 2688–2695.

37. Shander A, Javidroozi M. Blood conservation strategies and the management of perioperative anaemia. Curr Opin Anaesthesiol 2015; 28(3): 356–363.

38. Scharman CD, Burger D, Shatzel JJ, et al. Treatment of individuals who cannot receive blood products for religious or other reasons. Am J Hematol 2017; 92(12): 1370–1381.

39. Slipac J. Bezkrevní medicína. 2. aktualizované vydání. Praha: Triton 2011.

40. Slipac J. Evropská příručka osvědčených postupů Patient Blood Management. Prakt. Lék. 2017; 97(5): 206–213.

41. Slipac J. Patient Blood Managment – Proč? Praha: Triton 2020.

42. Slipac J. Předoperační anemie: výskyt, příčiny, následky, diagnostika a léčba. Prakt. Lék. 2018; 98(3): 99–103.

43. Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 2019; 23(1): 98.

44. Ševčíková S, Durila M, Vymazal T. Vliv infuzních roztoků na krevní srážlivost. Anest Intenziv Med 2018; 29(5): 258–264.

45. Taeuber I, Weibel S, Herrmann E, et al. Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. JAMA Surg 2021; 156(6): e210884.

46. Tan GM, Guinn NR, Frank SM, Shander A. Proceedings from the Society for advancement of blood management Annual meeting 2017: Management dilemmas of the surgical patient – when blood is not an option. Anesth Analg 2019; 128(1): 144–151.

47. van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116(1): 35–48.

48. Varela JE, Gomez-Marin O, Fleming LE, Cohn SM. The risk of death for Jehovah’s Witnesses after major trauma. J Trauma 2003; 54(5): 967–972.

49. Vasques F, Kinnunen EM, Pol M, et al. Outcome of Jehovah’s Witnesses after adult cardiac surgery: systematic review and meta-analysis ofcomparative studies. Transfusion 2016; 56(8): 2146–2153.

50. Wu WW, Zhang WY, Zhang WH, et al. Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(27): e16040.